Transcatheter aortic valve implantation vs surgical aortic valve replacement in high-risk patients with aortic stenosis

Objective The aim was to demonstrate whether transcatheter aortic valve implantation (TAVI) improves mortality and morbidity compared with standard surgical aortic valve replacement (SAVR) in high-risk patients requiring intervention for aortic valve stenosis (AS). Many patients with severe AS and c...

Full description

Bibliographic Details
Main Author: Emad Sarawy
Format: Article
Language:English
Published: General Organization of Teaching Hospitals and Institutes 2020-01-01
Series:Journal of Medicine in Scientific Research
Subjects:
Online Access:http://www.jmsr.eg.net/article.asp?issn=2537-091X;year=2020;volume=3;issue=3;spage=227;epage=232;aulast=Sarawy
_version_ 1827298013428580352
author Emad Sarawy
author_facet Emad Sarawy
author_sort Emad Sarawy
collection DOAJ
description Objective The aim was to demonstrate whether transcatheter aortic valve implantation (TAVI) improves mortality and morbidity compared with standard surgical aortic valve replacement (SAVR) in high-risk patients requiring intervention for aortic valve stenosis (AS). Many patients with severe AS and coexisting morbidity are not candidates for surgical replacement of the aortic valve (AV). TAVI has been suggested as an alternative less invasive treatment for high-risk patients with AS. Patients and methods A total of 50 patients with high-risk severe AS for AV intervention were classified into: group A, the TAVI group, including 25 patients who underwent AV replacement via the transcatheter femoral approach and group B, the SAVR group, including 25 patients who underwent standard SAVR via median sternotomy. Results Intraoperatively, procedure duration was 101.8 ± 10.6 and 191.2 ± 7.5 min in group A and B, respectively (P < 0.001). Major vascular complications occurred in 20% of patients in group A vs 0% of patients in group B (P = 0.018). Postoperative follow-up, mean ICU stay was 3 ± 2.4 and 4.8 ± 3.5 days in group A and group B, respectively (P = 0.035). In group A, 32% of patients needed permanent pacemakers. In group A, 12% of patients developed stroke or transient ischemic attacks. Paravalvular aortic regurgitation occurred in 36.3 and 4.5% of patients in group A and group B, respectively (P = 0.009). Conclusions In high-risk patients with severe AS, transcatheter and surgical procedures for aortic-valve replacement were comparable for survival at 3 months, although there were important differences in periprocedural outcomes.
first_indexed 2024-04-24T15:07:00Z
format Article
id doaj.art-06b06a879036456abdc321b4fb400e81
institution Directory Open Access Journal
issn 2537-091X
2537-0928
language English
last_indexed 2024-04-24T15:07:00Z
publishDate 2020-01-01
publisher General Organization of Teaching Hospitals and Institutes
record_format Article
series Journal of Medicine in Scientific Research
spelling doaj.art-06b06a879036456abdc321b4fb400e812024-04-02T12:39:15ZengGeneral Organization of Teaching Hospitals and InstitutesJournal of Medicine in Scientific Research2537-091X2537-09282020-01-013322723210.4103/JMISR.JMISR_16_20Transcatheter aortic valve implantation vs surgical aortic valve replacement in high-risk patients with aortic stenosisEmad SarawyObjective The aim was to demonstrate whether transcatheter aortic valve implantation (TAVI) improves mortality and morbidity compared with standard surgical aortic valve replacement (SAVR) in high-risk patients requiring intervention for aortic valve stenosis (AS). Many patients with severe AS and coexisting morbidity are not candidates for surgical replacement of the aortic valve (AV). TAVI has been suggested as an alternative less invasive treatment for high-risk patients with AS. Patients and methods A total of 50 patients with high-risk severe AS for AV intervention were classified into: group A, the TAVI group, including 25 patients who underwent AV replacement via the transcatheter femoral approach and group B, the SAVR group, including 25 patients who underwent standard SAVR via median sternotomy. Results Intraoperatively, procedure duration was 101.8 ± 10.6 and 191.2 ± 7.5 min in group A and B, respectively (P < 0.001). Major vascular complications occurred in 20% of patients in group A vs 0% of patients in group B (P = 0.018). Postoperative follow-up, mean ICU stay was 3 ± 2.4 and 4.8 ± 3.5 days in group A and group B, respectively (P = 0.035). In group A, 32% of patients needed permanent pacemakers. In group A, 12% of patients developed stroke or transient ischemic attacks. Paravalvular aortic regurgitation occurred in 36.3 and 4.5% of patients in group A and group B, respectively (P = 0.009). Conclusions In high-risk patients with severe AS, transcatheter and surgical procedures for aortic-valve replacement were comparable for survival at 3 months, although there were important differences in periprocedural outcomes.http://www.jmsr.eg.net/article.asp?issn=2537-091X;year=2020;volume=3;issue=3;spage=227;epage=232;aulast=Sarawyaortic valve stenosissternotomytranscatheter aortic valve implantation
spellingShingle Emad Sarawy
Transcatheter aortic valve implantation vs surgical aortic valve replacement in high-risk patients with aortic stenosis
Journal of Medicine in Scientific Research
aortic valve stenosis
sternotomy
transcatheter aortic valve implantation
title Transcatheter aortic valve implantation vs surgical aortic valve replacement in high-risk patients with aortic stenosis
title_full Transcatheter aortic valve implantation vs surgical aortic valve replacement in high-risk patients with aortic stenosis
title_fullStr Transcatheter aortic valve implantation vs surgical aortic valve replacement in high-risk patients with aortic stenosis
title_full_unstemmed Transcatheter aortic valve implantation vs surgical aortic valve replacement in high-risk patients with aortic stenosis
title_short Transcatheter aortic valve implantation vs surgical aortic valve replacement in high-risk patients with aortic stenosis
title_sort transcatheter aortic valve implantation vs surgical aortic valve replacement in high risk patients with aortic stenosis
topic aortic valve stenosis
sternotomy
transcatheter aortic valve implantation
url http://www.jmsr.eg.net/article.asp?issn=2537-091X;year=2020;volume=3;issue=3;spage=227;epage=232;aulast=Sarawy
work_keys_str_mv AT emadsarawy transcatheteraorticvalveimplantationvssurgicalaorticvalvereplacementinhighriskpatientswithaorticstenosis